Short report: 4-Aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome
Open Access
- 1 November 1977
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 40 (11), 1109-1112
- https://doi.org/10.1136/jnnp.40.11.1109
Abstract
A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.This publication has 7 references indexed in Scilit:
- CLINICAL, NEUROPHYSIOLOGICAL AND MORPHOLOGICAL FINDINGS IN EATON LAMBERT SYNDROMEActa Neurologica Scandinavica, 2009
- Antagonism of the paralysis produced by botulinum toxin in the ratJournal of the Neurological Sciences, 1977
- The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminalsEuropean Journal of Pharmacology, 1977
- Guanidine and germine in Eaton‐Lambert syndromeNeurology, 1976
- [Pharmacological approach to the study of convulsive action mechanism of amino-4 pyridine].1971
- Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma.1968
- DEFECTS OF NEUROMUSCULAR TRANSMISSION IN SYNDROMES OTHER THAN MYASTHENIA GRAVISAnnals of the New York Academy of Sciences, 1966